Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Cancer cells reprogram their copper metabolism to adapt to adverse microenvironments, such as oxidative stress. The copper chelator elesclomol has been reported to have considerable anticancer efficacy, but the underlying mechanisms remain largely unknown. In this study, we found that elesclomol‐med...
Saved in:
Main Authors: | Wei Gao, Zhao Huang, Jiufei Duan, Edouard C. Nice, Jie Lin, Canhua Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a004c29e4a7447ccb26c7e8b78992a28 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood Copper Levels and the Occurrence of Colorectal Cancer in Poland
by: Piotr Baszuk, et al.
Published: (2021) -
Zinc oxide nanosphere for hydrogen sulfide scavenging and ferroptosis of colorectal cancer
by: Xiang Pan, et al.
Published: (2021) -
Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease
by: Chengfei Xu, et al.
Published: (2021) -
Nanoparticles for Ferroptosis Therapy in Cancer
by: Nadia Zaffaroni, et al.
Published: (2021) -
The role of ferroptosis in lung cancer
by: Sikai Wu, et al.
Published: (2021)